+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nucleic Acid Labeling - Global Strategic Business Report

  • PDF Icon

    Report

  • 179 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805946
The global market for Nucleic Acid Labeling was estimated at US$2.9 Billion in 2023 and is projected to reach US$4.8 Billion by 2030, growing at a CAGR of 7.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Why Is Nucleic Acid Labeling Important in Modern Molecular Biology?

Nucleic acid labeling is a crucial process in molecular biology and biotechnology, enabling the detection, visualization, and quantification of DNA, RNA, and other nucleic acids in various research and diagnostic applications. Labels can be fluorescent, radioactive, or enzymatic, and they are used in techniques such as in situ hybridization, PCR, microarrays, and sequencing. These labeling techniques are essential for studying gene expression, detecting genetic mutations, and understanding molecular interactions at a detailed level. As research in genomics and precision medicine accelerates, nucleic acid labeling is becoming increasingly critical in both clinical diagnostics and life sciences research, where accuracy and sensitivity are paramount.

How Are Technological Advancements Shaping the Nucleic Acid Labeling Market?

Technological advancements in nucleic acid labeling are driving growth in both research and clinical applications. Innovations in fluorescent labeling and dye chemistry are enhancing the sensitivity and specificity of detection techniques, allowing for clearer and more accurate results. Next-generation labeling kits and reagents are also simplifying the process, reducing the time and complexity involved in traditional labeling methods. Additionally, automated labeling systems are gaining popularity in high-throughput environments, such as large-scale genomic studies and pharmaceutical research. These advancements are improving the efficiency and scalability of nucleic acid labeling processes, making it easier for laboratories to handle larger sample volumes and more complex experiments.

What Impact Does the Rise of Genomics and Diagnostics Have on Nucleic Acid Labeling?

The increasing focus on genomics and personalized medicine is significantly influencing the nucleic acid labeling market. As genetic sequencing and molecular diagnostics become more integral to healthcare, the demand for accurate and efficient nucleic acid labeling methods is rising. In clinical diagnostics, labeled nucleic acids are essential for detecting genetic disorders, infectious diseases, and cancers, where precision is critical for effective treatment decisions. In addition, the growth of high-throughput technologies, such as next-generation sequencing (NGS) and CRISPR-based gene editing, is expanding the need for advanced labeling techniques that can support large-scale, rapid analysis of genetic material. This trend is also being driven by increasing investments in genomics research and the rise of biopharmaceutical innovations.

Growth in the Nucleic Acid Labeling Market Is Driven by Several Factors

Growth in the nucleic acid labeling market is driven by several factors, including advancements in molecular biology techniques, the expanding application of genomics, and the rising demand for high-precision diagnostic tools. The proliferation of next-generation sequencing (NGS) technologies and the growing use of personalized medicine are increasing the need for sophisticated nucleic acid labeling methods. Technological innovations in fluorescent and enzymatic labeling are enabling faster, more accurate results in both research and clinical settings. Additionally, the increasing adoption of automated and high-throughput labeling systems is enhancing workflow efficiency in laboratories. Growing research into cancer diagnostics, genetic diseases, and infectious pathogens is further fueling demand for labeling technologies that support rapid, sensitive nucleic acid detection and analysis. Government funding for genomics research and healthcare advancements is also contributing to the market's expansion.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Nucleic Acid Labeling Reagents segment, which is expected to reach US$2.4 Billion by 2030 with a CAGR of a 8.3%. The Nucleic Acid Labeling Kits segment is also set to grow at 7.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was valued at $797.5 Million in 2023, and China, forecasted to grow at an impressive 6.9% CAGR to reach $737.1 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Nucleic Acid Labeling Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Nucleic Acid Labeling Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Nucleic Acid Labeling Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Agilent Technologies, Inc., Enzo Biochem, Inc., F. Hoffmann-La Roche AG, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 12 Featured):

  • Agilent Technologies, Inc.
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • Merck KgaA
  • New England Biolabs, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
  • Vector Laboratories, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Nucleic Acid Labeling - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Demand for Molecular Diagnostics and Research Drives Growth in Nucleic Acid Labeling Applications
  • Advances in Fluorescent and Radioactive Labeling Technologies Expand Opportunities in DNA/RNA Labeling for Diagnostics
  • Rising Use of Nucleic Acid Labeling in Next-Generation Sequencing (NGS) and PCR Amplification Fuels Market Demand
  • Expanding Role of Genetic and Epigenetic Research Spurs the Adoption of Novel Nucleic Acid Labeling Methods
  • Growing Importance of Gene Expression Profiling Strengthens the Business Case for Labeling Techniques in Transcriptomics
  • Development of Cost-Effective and High-Sensitivity Labeling Kits Propels Growth in Clinical and Research Applications
  • Increasing Adoption of In-Situ Hybridization (ISH) Techniques Drives Demand for High-Precision Nucleic Acid Labeling
  • Growing Role of CRISPR-Based Research in Gene Editing Expands the Need for Advanced Nucleic Acid Labeling Technologies
  • Rising Focus on Personalized Medicine and Biomarker Discovery Spurs Market Demand for Innovative Labeling Solutions
  • Advances in Non-Radioactive Labeling Techniques Propel Growth in Safe and Environmentally Friendly Labeling Solutions
  • Rising Use of Labeling in Single-Cell Analysis Strengthens Demand for High-Specificity Nucleic Acid Labeling Kits
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Nucleic Acid Labeling Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 3: World 7-Year Perspective for Nucleic Acid Labeling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World 7-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 7: World 7-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 9: World 7-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World 7-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 12: World Recent Past, Current & Future Analysis for Nick Translation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 13: World 7-Year Perspective for Nick Translation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Random Primer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 15: World 7-Year Perspective for Random Primer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for In Vitro Transcription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 17: World 7-Year Perspective for In Vitro Transcription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 18: World Recent Past, Current & Future Analysis for Reverse Transcription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 19: World 7-Year Perspective for Reverse Transcription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Other Labeling Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 21: World 7-Year Perspective for Other Labeling Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for in Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 23: World 7-Year Perspective for in Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 24: World Recent Past, Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 25: World 7-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 27: World 7-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Fluorescence in Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 29: World 7-Year Perspective for Fluorescence in Situ Hybridization (FISH) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 30: World Recent Past, Current & Future Analysis for Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 31: World 7-Year Perspective for Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • Table 32: World Recent Past, Current & Future Analysis for Blotting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 33: World 7-Year Perspective for Blotting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 34: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 35: USA 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
  • Table 36: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 37: USA 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
  • Table 38: USA Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: USA 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
CANADA
  • Table 40: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 41: Canada 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
  • Table 42: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 43: Canada 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
  • Table 44: Canada Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: Canada 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
JAPAN
  • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 46: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 47: Japan 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
  • Table 48: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 49: Japan 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
  • Table 50: Japan Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: Japan 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
CHINA
  • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 52: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 53: China 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
  • Table 54: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 55: China 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
  • Table 56: China Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 57: China 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
EUROPE
  • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 58: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 59: Europe 7-Year Perspective for Nucleic Acid Labeling by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • Table 60: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 61: Europe 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
  • Table 62: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 63: Europe 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
  • Table 64: Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 65: Europe 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
FRANCE
  • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 66: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 67: France 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
  • Table 68: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 69: France 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
  • Table 70: France Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 71: France 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
GERMANY
  • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 72: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 73: Germany 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
  • Table 74: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 75: Germany 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
  • Table 76: Germany Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 77: Germany 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
ITALY
  • Table 78: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 79: Italy 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
  • Table 80: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 81: Italy 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
  • Table 82: Italy Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 83: Italy 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
UNITED KINGDOM
  • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 84: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 85: UK 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
  • Table 86: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 87: UK 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
  • Table 88: UK Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 89: UK 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
REST OF EUROPE
  • Table 90: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 91: Rest of Europe 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of Europe 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
  • Table 94: Rest of Europe Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 95: Rest of Europe 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
ASIA-PACIFIC
  • Nucleic Acid Labeling Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 96: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 97: Asia-Pacific 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 99: Asia-Pacific 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
  • Table 100: Asia-Pacific Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 101: Asia-Pacific 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
REST OF WORLD
  • Table 102: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Product - Reagents, Kits and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 103: Rest of World 7-Year Perspective for Nucleic Acid Labeling by Product - Percentage Breakdown of Value Sales for Reagents, Kits and Instruments for the Years 2024 & 2030
  • Table 104: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Labeling Techniques - PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 105: Rest of World 7-Year Perspective for Nucleic Acid Labeling by Labeling Techniques - Percentage Breakdown of Value Sales for PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription and Other Labeling Techniques for the Years 2024 & 2030
  • Table 106: Rest of World Recent Past, Current & Future Analysis for Nucleic Acid Labeling by Application - in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 107: Rest of World 7-Year Perspective for Nucleic Acid Labeling by Application - Percentage Breakdown of Value Sales for in Situ Hybridization, DNA Sequencing, Polymerase Chain Reaction (PCR), Fluorescence in Situ Hybridization (FISH), Microarrays and Blotting for the Years 2024 & 2030
IV. COMPETITION

Companies Mentioned

  • Agilent Technologies, Inc.
  • Enzo Biochem, Inc.
  • F. Hoffmann-La Roche AG
  • General Electric Company
  • Merck KgaA
  • New England Biolabs, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.
  • Vector Laboratories, Inc.

Table Information